Lupus nephritis biomarkers

Samar Soliman, Chandra Mohan

Research output: Contribution to journalArticlepeer-review

65 Scopus citations


Lupus nephritis (LN), a potentially destructive outcome of SLE, is a real challenge in the management of SLE because of the difficulty in diagnosing its subclinical onset and identifying relapses before serious complications set in. Conventional clinical parameters such as proteinuria, GFR, urine sediments, anti-dsDNA and complement levels are not sensitive or specific enough for detecting ongoing disease activity in lupus kidneys and early relapse of nephritis. There has long been a need for biomarkers of disease activity in LN. Such markers ideally should be capable of predicting early sub-clinical flares and could be used to gauge response to therapy, thus obviating the need for serial renal biopsies with their possible hazardous complications. Since urine can be readily obtained, it lends itself as an obvious biological substrate. In this review, the use of urine and serum as sources of lupus nephritis biomarkers is described, and the results of biomarker discovery studies using candidate and proteomic approaches are summarized.

Original languageEnglish (US)
JournalClinical Immunology
StateAccepted/In press - Jun 23 2016


  • Adhesion molecules
  • Biomarkers
  • Chemokines
  • Cytokines
  • Diagnostics
  • Proteomics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Medicine(all)


Dive into the research topics of 'Lupus nephritis biomarkers'. Together they form a unique fingerprint.

Cite this